Stock Market Reviews

Read and share opinions on CSBR (Champions Oncology, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• Champions Oncology First Quarter 2026 Earnings: US$0.032 loss per share (vs US$0.097 profit in 1Q 2025)
  Sep 17, 2025
• Champions Oncology Inc (CSBR) Q1 2026 Earnings Call Highlights: Revenue Rebound and Strategic ...
  Sep 16, 2025
• CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
  Sep 15, 2025
• Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
  Sep 15, 2025
• Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
  Sep 10, 2025
• Champions Oncology Inc (CSBR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ...
  Jul 24, 2025
• Champions Oncology Reports Record Annual Revenue of $57 Million
  Jul 23, 2025
• Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
  Jul 21, 2025
• Champions Oncology Announces Appointment of New CEO
  Jul 18, 2025
• Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
  Jul 8, 2025
• Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
  Apr 28, 2025
• Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
  Apr 24, 2025
• Champions Oncology Inc (CSBR) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ...
  Apr 21, 2025
• Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their respectable 47% return over the last year
  Apr 13, 2025
• Champions Oncology Third Quarter 2025 Earnings: EPS: US$0.33 (vs US$0.19 loss in 3Q 2024)
  Mar 13, 2025
• Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
  Mar 11, 2025
• Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
  Mar 6, 2025
• Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
  Feb 18, 2025